News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
The 2024 NKICF Career Development has been awarded to Dr. Gabriela Inés Villanueva and Dr. Prasanth Srinivasan -International Society of Paediatric Oncology
A collage photo of Gabriela Inés Villanueva and Prasanth Srinivasan
Jan 24, 2024, 17:56

The 2024 NKICF Career Development has been awarded to Dr. Gabriela Inés Villanueva and Dr. Prasanth Srinivasan -International Society of Paediatric Oncology

International Society of Paediatric Oncology posted on their LinkedIn page:

“The 2024 NKICF Career Development has been awarded to Dr. Gabriela Inés Villanueva (Argentina) who will study the development of strategies to facilitate and incentivize the inclusion of AYA patients in regional clinical trials, and Dr. Prasanth Srinivasan (India) who will study Pediatric High-Grade Mature B-cell Non-Hodgkin Lymphoma.

Congratulations Dr. Villanueva and Dr. Srinivasan!”

More information about Dr. Villanueva.
More information about Dr. Srinivasan.
Source: International Society of Paediatric Oncology/LinkedIn and International Society of Paediatric Oncology/LinkedIn

2024 NKICF Career Development cancer Gabriela Inés Villanueva International Society of Paediatric Oncology OncoDaily Oncology Prasanth Srinivasan SIOP Programme to Advance Research Capacity (SIOP PARC)
Special Coverage
Blog
Dec 22, 2024, 11:49
EU’s Last Plenary Session of 2024
Career
Dec 22, 2024, 11:42
OncoInfluencers to Follow on Social Media: Dr. Alejandro Aballay
Insight
Dec 22, 2024, 11:22
Omar Alhalabi: Antiangiogenesis and immune checkpoint blockade in urothelial cancer
Blog
Dec 22, 2024, 10:51
Gemma Peters: Heading into 2025 with hope
Science
Dec 22, 2024, 10:44
5 papers about Lung Cancer suggested by Stephen Liu
Science
Dec 22, 2024, 10:15
Dégi László Csaba: Thrilled to announce the new Lancet Oncology Policy Review analyzing NCCPs worldwide
Science
Dec 22, 2024, 10:13
Denis Horgan: Delayed Access to Personalized Medicine in the EU - What’s the Cost to Patients?
Blog
Dec 22, 2024, 10:12
Emad Shash: Honor to be among the newly elected council of the Egyptian Cancer Society
Science
Dec 22, 2024, 10:03
María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy
Science
Dec 22, 2024, 10:00
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Science
Dec 22, 2024, 09:59
CDK4/6 inhibitors: mechanisms of resistance and where to find them - Lorenzo Gerratana
Blog
Dec 22, 2024, 09:53
India's Oncology Testing Market Projected to Grow at 2% CAGR Through 2033: GlobalData